Annual report
Page 1
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington , D.C. 20549 FORM 10 - K > ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 ( D ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31 , 2020 □ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 ( D ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from Delaware ( State or other jurisdiction of incorporation or organization ) Commission file number : 001-39565 VESPER HEALTHCARE ACQUISITION CORP . ( Exact name of registrant as specified in its charter ) 1819 West Avenue , Bay 2 Miami Beach ( Address of principal executive offices ) Title of Each Class : Shares of Class A Common Stock , par value $ 0.0001 per share Redeemable Warrants , each whole warrant exercisable for one share of Class A Common Stock for $ 11.50 per share , subject to adjustment Registrant's telephone number , including area code : ( 786 ) 216-7037 Securities registered pursuant to Section 12 ( b ) of the Act : Trading Symbol ( s ) Units , each consisting of one share of Class A Common Stock and one - third of one Redeemable Warrant VSPR to VSPRW ☐ > > VSPRU 85-1908962 ( I.R.S. Employer Identification Number ) 33139 ( Zip Code ) Name of Each Exchange on Which Registered : The Nasdaq Stock Market LLC The Nasdaq Stock Market LLC Securities registered pursuant to Section 12 ( g ) of the Act : None Indicate by check mark if the registrant is a well - known seasoned issuer , as defined in Rule 405 of the Securities Act . Yes No X Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15 ( d ) of the Exchange Act . Yes No | Indicate by check mark whether the registrant ( 1 ) has filed all reports required to be filed by Section 13 or 15 ( d ) of the Securities Exchange Act of 1934 during the preceding 12 months ( or for such shorter period that the registrant was required to file such reports ) , and ( 2 ) has been subject to such filing requirements for the past 90 days . Yes > No The Nasdaq Stock Market LLC Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S - T ( § 232.405 of this chapter ) during the preceding 12 months ( or for such shorter period that the registrant was required to submit and post such files ) . Yes > No Accelerated filer Smaller reporting company Indicate by check mark whether the registrant is a large accelerated filer , an accelerated filer , a non - accelerated filer , a smaller reporting company or an emerging growth company . See definition of " large accelerated filer , " " accelerated filer , “ smaller reporting company " and " emerging growth company " in Rule 12b - 2 of the Exchange Act . Large accelerated filer Non - accelerated filer Emerging growth company If an emerging growth company , indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13 ( a ) of the Exchange Act . 口 Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404 ( b ) of the Sarbanes - Oxley Act ( 15 U.S.C. 7262 ( b ) ) by the registered public accounting firm that prepared or issued its audit report . □ Indicate by check mark whether the registrant is a shell company ( as defined in Rule 12b - 2 of the Exchange Act ) . Yes > No The registrant's shares were not listed on any exchange and had no value as of the last business day of the second fiscal quarter of 2020. The registrant's units began trading on The Nasdaq Capital Market on September 30 , 2020. The registrant's shares of Class A common stock and warrants began trading on The Nasdaq Capital Market on November 20 , 2020. The aggregate market value of the units outstanding , other than shares held by persons who may be deemed affiliates of the registrant , computed by reference to the closing price for the units on December 31 , 2020 , as reported on the Nasdaq Capital Market was $ 557,520,000 . As of March 17 , 2021 , there were 46,000,000 shares of the Company's Class A common stock , par value $ 0.0001 per share ( " Class A Common stock " ) and 11,500,000 shares of the Company's Class B common stock , par value $ 0.0001 per share ( " Class B Common stock " ) issued and